SCHEMBL8326243

SCHEMBL8326243

O=C(Nc1cccnc1)c1ccc(OCC2CC2)c2oc3c(c12)CCCC3

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.51
PDE4B Q07343 1/20 0.51
PDE4C Q08493 1/20 0.51
PDE4D Q08499 1/20 0.51
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
ALDH1A1 P00352 2/20 0.48
LMNA P02545 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
TP53 P04637 2/20 0.47
GSK3A P49840 1/20 0.45
SGMS2 Q8NHU3 4/20 0.43
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
KDM4C Q9H3R0 1/20 0.41
LRRK2 Q5S007 5/20 0.40
EGLN1 Q9GZT9 1/20 0.40
USP2 O75604 1/20 0.40
MAPK1 P28482 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8327267 0.89 PDE4A (0.42) PDE4APDE4BPDE4CPDE4DLMNA
SCHEMBL8318915 0.88 NPC1 (0.50) NPC1RAB9AALDH1A1LMNANPSR1
SCHEMBL8320435 0.83 PDE4D (0.50) PDE4APDE4BPDE4CPDE4D
SCHEMBL5022728 0.83 PDE4A (0.51) PDE4APDE4BPDE4CPDE4DNPC1
SCHEMBL8325539 0.83 ALDH1A1 (0.50) PDE4APDE4BPDE4CPDE4DNPC1
SCHEMBL8325509 0.78 GAA (0.49) PDE4APDE4BPDE4CPDE4DNPC1
SCHEMBL8324499 0.77 CNR2 (0.35) PDE4APDE4BPDE4CPDE4DHTR2A
SCHEMBL8324668 0.73 PDE4A (0.59) PDE4APDE4BPDE4CPDE4DNPC1
SCHEMBL5017972 0.72 CYP19A1 (0.51) PDE4APDE4BPDE4CPDE4DNPC1
SCHEMBL8318940 0.72 PDE4A (0.58) PDE4APDE4BPDE4CPDE4DNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004069831-A1 TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS LTD. (US) 2004-08-19 WO disclosed